Heron Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 26.71 M | $40.87 M | 0.00% | 17.48% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 8.59 M | $13.14 M | 0.66% | 5.62% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 8.50 M | $13.01 M | -3.95% | 5.56% |
VANGUARD GROUP INC | 02/11/2025 | 8.16 M | $12.48 M | -6.45% | 5.34% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 6.99 M | $10.69 M | 0.00% | 4.57% |
TEJARA CAPITAL LTD | 02/10/2025 | 4.66 M | $7.13 M | -12.14% | 3.05% |
PALISADE CAPITAL MANAGEMENT, LP | 02/14/2025 | 3.93 M | $6.01 M | -1.65% | 2.57% |
D. E. SHAW & CO., INC. | 02/14/2025 | 3.72 M | $5.70 M | -15.07% | 2.44% |
STATE STREET CORP | 02/14/2025 | 3.15 M | $4.81 M | -1.45% | 2.06% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 3.08 M | $4.71 M | 100.00% | 2.01% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.02 M | $4.61 M | -0.99% | 1.97% |
CONGRESS PARK CAPITAL LLC | 01/15/2025 | 2.46 M | $3.76 M | 24.14% | 1.61% |
JW ASSET MANAGEMENT, LLC | 02/07/2025 | 2.29 M | $3.51 M | 0.00% | 1.50% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.14 M | $3.27 M | 15.69% | 1.40% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.94 M | $2.97 M | 4,731.09% | 1.27% |
ORCHARD CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.88 M | $2.84 M | -5.24% | 1.23% |
CLEARLINE CAPITAL LP | 02/14/2025 | 1.81 M | $2.77 M | -18.69% | 1.18% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 1.32 M | $2.02 M | 3.21% | 0.86% |
MONACO ASSET MANAGEMENT SAM | 02/10/2025 | 1.21 M | $1.86 M | -27.74% | 0.79% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.19 M | $1.82 M | -40.80% | 0.78% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.11 M | $1.69 M | 0.86% | 0.72% |
MARSHALL WACE, LLP | 02/13/2025 | 1.02 M | $1.56 M | -40.69% | 0.67% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 990,169 | $1.51 M | -29.38% | 0.65% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 823,871 | $1.26 M | 1.54% | 0.54% |
STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 700,000 | $1.07 M | 100.00% | 0.46% |
CM MANAGEMENT, LLC | 02/07/2025 | 700,000 | $1.07 M | 40.00% | 0.46% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 655,160 | $1.00 M | -61.62% | 0.43% |
RICHMOND BROTHERS, INC. | 02/11/2025 | 642,339 | $982,779 | 25.76% | 0.42% |
JPMORGAN CHASE & CO | 02/12/2025 | 562,764 | $861,029 | 172.25% | 0.37% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 488,122 | $746,826 | -1.63% | 0.32% |
NEXPOINT ASSET MANAGEMENT, L.P. | 02/14/2025 | 475,750 | $727,898 | 0.00% | 0.31% |
QUINN OPPORTUNITY PARTNERS LLC | 02/13/2025 | 380,000 | $581,400 | 100.00% | 0.25% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 340,710 | $521,287 | -0.01% | 0.22% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 314,275 | $480,841 | -71.60% | 0.21% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 300,000 | $459,000 | 100.00% | 0.20% |
XTX TOPCO LTD | 02/13/2025 | 297,485 | $455,152 | -0.03% | 0.19% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 277,344 | $424,336 | 0.51% | 0.18% |
J. GOLDMAN & CO LP | 02/14/2025 | 270,100 | $413,253 | 100.00% | 0.18% |
APEIRON RIA LLC | 01/17/2025 | 262,542 | $401,689 | 7.80% | 0.17% |
BARCLAYS PLC | 02/13/2025 | 241,346 | $370,000 | 10.48% | 0.16% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 215,531 | $329,762 | -76.93% | 0.14% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 214,957 | $328,884 | -76.12% | 0.14% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 198,550 | $303,782 | 0.00% | 0.13% |
FMR LLC | 02/13/2025 | 191,886 | $293,586 | -55.57% | 0.13% |
RHUMBLINE ADVISERS | 01/30/2025 | 177,681 | $271,837 | 1.08% | 0.12% |
UBS GROUP AG | 02/14/2025 | 159,476 | $243,998 | 87.06% | 0.10% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 135,722 | $207,655 | 100.00% | 0.09% |
ZWEIG-DIMENNA ASSOCIATES LLC | 01/21/2025 | 128,592 | $196,746 | 0.00% | 0.08% |
ANFIELD CAPITAL MANAGEMENT, LLC | 02/05/2025 | 118,976 | $182,033 | 5.56% | 0.08% |
PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 113,560 | $173,747 | 10.63% | 0.07% |
Heron Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 256 institutional investors and hedge funds held shares of Heron Therapeutics, Inc.. The most heavily invested institutionals were:
Rubric Capital Management LP: 26.71 M
BlackRock Funding, Inc. /DE: 8.59 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 8.5 M
VANGUARD GROUP INC: 8.16 M
Velan Capital Investment Management LP: 6.99 M
Tejara Capital Ltd: 4.66 M
75.22% of Heron Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 136.63 M shares in the last 24 months. This purchase volume represents approximately $244.57 M in transactions.